Is Sennelitics Making Sense on the Big Stage?

Sennelitics has pivoted away from that specific indication. They're now most advanced programs called UBX1325 and it targets senescent cells in the vasculature of the eye. Altos Labs doesn't call themselves an anti-aging company or a longevity company. They call themselves kind of a regenerative medicine company. So those were, you know, two of the companies that I'm looking forward to seeing what's next for them.